Entity Common Stock, Shares Outstanding of Lyell Immunopharma, Inc. from 09 Aug 2021 to 10 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lyell Immunopharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Aug 2021 to 10 Nov 2025.
  • Lyell Immunopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2025 was 21,218,217, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Lyell Immunopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 21,218,217 -258,002,397 -92% 10 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 19,211,202 -236,791,911 -92% 07 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 295,228,868 +40,289,646 +16% 06 Mar 2025 10-K 11 Mar 2025 2024 FY
Q3 2024 279,220,614 +27,351,646 +11% 05 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 256,003,113 +4,976,116 +2% 02 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 254,939,222 +5,329,975 +2.1% 02 May 2024 10-Q 06 May 2024 2024 Q1
Q3 2023 251,868,968 +2,543,341 +1% 02 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 251,026,997 +3,201,651 +1.3% 03 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 249,609,247 +4,221,197 +1.7% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 249,325,627 +8,854,130 +3.7% 03 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 247,825,346 +8,427,140 +3.5% 01 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 245,388,050 25 Mar 2022 10-K 29 Mar 2022 2021 FY
Q3 2021 240,471,497 05 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 239,398,206 09 Aug 2021 10-Q 12 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.